CHEK2 and posterior cortical atrophy: We will evaluate whether it could predict PCa death and provide additional assessment over P/LP variants of hereditary cancer susceptibility genes (ATM, BRCA1, BRCA2, CHEK2, PALB2, MLH1, MSH2, MSH6, PMS2, and HOXB13).